Postoperative surveillance imaging for patients undergoing nephrectomy for renal cell carcinoma

被引:8
作者
Kim, Eric H. [1 ]
Strope, Seth A. [1 ]
机构
[1] Washington Univ, Div Urol, St Louis, MO 63110 USA
关键词
Renal cell carcinoma; Surveillance; Recurrence; Diagnostic imaging; PROGNOSTIC NOMOGRAM; COST-EFFECTIVENESS; LATE RECURRENCE; FOLLOW-UP; RISK; MANAGEMENT; SURGERY; MULTICENTER; SURVIVAL; OUTCOMES;
D O I
10.1016/j.urolonc.2015.08.008
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The American Urological Association and the National Comprehensive Cancer Network guidelines regarding postoperative surveillance for renal cell carcinoma (RCC) have provided a standardized framework for imaging following nephrectomy. These stage-stratified recommendations are based on retrospective studies that identified the timeline and location of RCC recurrences. However, the simplified and generalizable protocols offered by the American Urological Association and the National Comprehensive Cancer Network are not without limitations. Studies have found that RCC recurrences continue to be missed even with perfect compliance to these protocols and that RCC recurrences occur not infrequently after the required surveillance window of 5 years. Furthermore, recent studies evaluating the use of adjuvant systemic therapy in patients who are at a high risk for RCC recurrence or metastasis after nephrectomy have yielded disappointing results. This calls into question what interventions we can offer patients to improve survival once RCC recurrences are detected during postoperative surveillance; an effective surveillance strategy requires effective treatment options. The future of personalized medicine with genetic profiling of patients with RCC may offer a potential solution by providing better risk stratification to determine the intensity of surveillance imaging as well as to determine which patients will actually derive survival benefit from intervention on recurrent disease. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:499 / 502
页数:4
相关论文
共 26 条
[1]   Identifying the risk of disease progression after surgery for localized renal cell carcinoma [J].
Abel, E. Jason ;
Culp, Stephen H. ;
Meissner, Matthew ;
Matin, Surena F. ;
Tamboli, Pheroze ;
Wood, Christopher G. .
BJU INTERNATIONAL, 2010, 106 (09) :1277-1283
[2]   Adjuvant 5-flurouracil, alpha-interferon and interleukin-2 versus observation in patients at high risk of recurrence after nephrectomy for renal cell carcinoma: Results of a Phase III randomised European Organisation for Research and Treatment of Cancer (Genito-Urinary Cancers Group)/National Cancer Research Institute trial [J].
Aitchison, M. ;
Bray, C. A. ;
Van Poppel, H. ;
Sylvester, R. ;
Graham, J. ;
Innes, C. ;
McMahon, L. ;
Vasey, P. A. .
EUROPEAN JOURNAL OF CANCER, 2014, 50 (01) :70-77
[3]   The follow-up management of non-metastatic renal cell carcinoma: definition of a surveillance protocol [J].
Antonelli, Alessandro ;
Cozzoli, Alberto ;
Zani, Danilo ;
Zanotelli, Tiziano ;
Nicolai, Maria ;
Cunico, Sergio Cosciani ;
Simeone, Claudio .
BJU INTERNATIONAL, 2007, 99 (02) :296-300
[4]   Features Associated with Recurrence Beyond 5 Years After Nephrectomy and Nephron-Sparing Surgery for Renal Cell Carcinoma: Development and Internal Validation of a Risk Model (PRELANE score) to Predict Late Recurrence Based on a Large Multicenter Database (CORONA/SATURN Project) [J].
Brookman-May, Sabine ;
May, Matthias ;
Shariat, Shahrokh F. ;
Xylinas, Evanguelos ;
Stief, Christian ;
Zigeuner, Richard ;
Chromecki, Thomas ;
Burger, Maximilian ;
Wieland, Wolf F. ;
Cindolo, Luca ;
Schips, Luigi ;
De Cobelli, Ottavio ;
Rocco, Bernardo ;
De Nunzio, Cosimo ;
Feciche, Bogdan ;
Truss, Michael ;
Gilfrich, Christian ;
Pahernik, Sascha ;
Hohenfellner, Markus ;
Zastrow, Stefan ;
Wirth, Manfred P. ;
Novara, Giacomo ;
Carini, Marco ;
Minervini, Andrea ;
Simeone, Claudio ;
Antonelli, Alessandro ;
Mirone, Vincenzo ;
Longo, Nicola ;
Simonato, Alchiede ;
Carmignani, Giorgio ;
Ficarra, Vincenzo .
EUROPEAN UROLOGY, 2013, 64 (03) :472-477
[5]   ClearCode34: A Prognostic Risk Predictor for Localized Clear Cell Renal Cell Carcinoma [J].
Brooks, Samira A. ;
Brannon, A. Rose ;
Parker, Joel S. ;
Fisher, Jennifer C. ;
Sen, Oishee ;
Kattan, Michael W. ;
Hakimi, A. Ari ;
Hsieh, James J. ;
Choueiri, Toni K. ;
Tamboli, Pheroze ;
Maranchie, Jodi K. ;
Hinds, Peter ;
Miller, C. Ryan ;
Nielsen, Matthew E. ;
Rathmell, W. Kimryn .
EUROPEAN UROLOGY, 2014, 66 (01) :77-84
[6]   Cost-Effectiveness Analysis of Nephron Sparing Options for the Management of Small Renal Masses [J].
Chang, Steven L. ;
Cipriano, Lauren E. ;
Harshman, Lauren C. ;
Garber, Alan M. ;
Chung, Benjamin I. .
JOURNAL OF UROLOGY, 2011, 185 (05) :1591-1597
[7]   A Multigene Assay Identifying Distinct Prognostic Subtypes of Clear Cell Renal Cell Carcinoma with Differential Response to Tyrosine Kinase Inhibition [J].
Choudhury, Yukti ;
Wei, Xiaona ;
Chu, Ying-Hsia ;
Ng, Lay Guat ;
Tan, Hui Shan ;
Koh, Valerie ;
Thike, Aye Aye ;
Poon, Eileen ;
Ng, Quan Sing ;
Toh, Chee Keong ;
Kanesvaran, Ravindran ;
Tan, Puay Hoon ;
Tan, Min-Han .
EUROPEAN UROLOGY, 2015, 67 (01) :17-20
[8]   Follow-up for Clinically Localized Renal Neoplasms: AUA Guideline [J].
Donat, Sherri M. ;
Diaz, Mireya ;
Bishoff, Jay Todd ;
Coleman, Jonathan A. ;
Dahm, Philipp ;
Derweesh, Ithaar H. ;
Herrell, S. Duke, III ;
Hilton, Susan ;
Jonasch, Eric ;
Lin, Daniel W. ;
Reuter, Victor E. ;
Chang, Sam S. .
JOURNAL OF UROLOGY, 2013, 190 (02) :407-416
[9]   Initial results from ASSURE (E2805): Adjuvant sorafenib or sunitinib for unfavorable renal carcinoma, an ECOG-ACRIN-led, NCTN phase III trial [J].
Haas, Naomi B. ;
Manola, Judith ;
Uzzo, Robert G. ;
Atkins, Michael B. ;
Wilding, George ;
Pins, Michael ;
Jewett, Michael A. S. ;
Kane, Christopher J. ;
Cella, David ;
Wagner, Lynne I. ;
Coomes, Bob ;
Wood, Christopher G. ;
Dutcher, Janice P. ;
Flaherty, Keith ;
DiPaola, Robert S. .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
[10]   Validation of Mammalian Target of Rapamycin Biomarker Panel in Patients with Clear Cell Renal Cell Carcinoma [J].
Haddad, Ahmed Q. ;
Kapur, Payal ;
Singla, Nirmish ;
Raman, Jay D. ;
Then, Matthew T. ;
Nuhn, Philipp ;
Buchner, Alexander ;
Bastian, Patrick ;
Seitz, Christian ;
Shariat, Shahrokh F. ;
Bensalah, Karim ;
Rioux-Leclercq, Nathalie ;
Sagalowsky, Arthur ;
Lotan, Yair ;
Margulis, Vitaly .
CANCER, 2015, 121 (01) :43-50